STOCK TITAN

Marpai Stock Price, News & Analysis

MRAI OTC Link

Company Description

Marpai, Inc. (MRAI) is a technology platform company in the finance and insurance sector that focuses on healthcare benefits administration. According to the company’s disclosures, Marpai operates subsidiaries that provide Third-Party Administration (TPA), Pharmacy Benefit Management (PBM) and value‑oriented health plan services to employers that directly pay for employee health benefits. Its Class A common stock trades on the OTCQX Market under the symbol MRAI.

Marpai states that it primarily competes in the large U.S. TPA market serving self‑funded employer health plans, a segment the company describes as representing hundreds of billions of dollars in annual claims. Through its Marpai Saves initiative, the company works to deliver what it describes as the healthiest member population for a given health plan budget. Marpai reports that it operates nationwide and offers access to leading provider networks, including Aetna and Cigna, while providing all core TPA services.

Business model and services

Based on its public communications, Marpai’s business model centers on acting as an independent national TPA for self‑funded employer health plans and on providing related PBM and health plan services. The company characterizes itself as a technology platform that supports employers who directly pay for employee health benefits. Through its TPA operations, Marpai administers health plans for self‑funded employers, and through its PBM activities, it offers pharmacy benefit services that are integrated with its broader health plan administration platform.

Marpai highlights the MarpaiRx PBM offering as an important part of its strategy. In company news, Marpai describes a relaunch of MarpaiRx as a pharmacy benefit management solution intended to provide transparency and cost reductions for health plans. The company states that MarpaiRx is aligned with the Marpai Saves vision and is designed to support self‑funded employer health plans with affordable, intelligent healthcare.

Technology platform focus

In multiple press releases, Marpai refers to itself as a technology platform company. It reports ongoing initiatives in automation and data‑driven claims management, and it links these initiatives to its TPA and PBM services. The company also notes that it offers integrated pharmacy benefits and describes MarpaiRx as being powered by a technology platform that supports real‑time optimization, provider and member portals, and analytics for health plan utilization and cost management.

Marpai’s disclosures emphasize the use of technology to manage healthcare costs, administer benefits and support employer clients. The company positions its technology‑enabled services as a way to help plan sponsors manage claims costs and to align member health outcomes with plan budgets.

Provider network access and partnerships

The company states that it operates nationwide and offers access to leading provider networks. In its public statements, Marpai notes that it provides access to networks including Aetna and Cigna. One news release describes a renewal of Marpai’s agreement to access the Aetna Signature Administrator (ASA) PPO network, which the company characterizes as a critical network access agreement. Marpai indicates that this renewal supports broad national access to Aetna’s network of providers for its self‑funded employer clients and their members.

Marpai also reports that it will offer the Aetna Faircost Optimizer as an integrated cost management tool for benefit plan administrators. According to the company, this tool is intended to help plan sponsors manage out‑of‑network claims costs and to enhance cost containment for self‑funded plans.

Self‑funded employer health plan focus

Throughout its news releases, Marpai consistently describes its target market as self‑funded employer health plans. The company states that it serves employers that directly pay for employee health benefits and that it competes in the TPA sector supporting these plans. Marpai’s disclosures reference the scale of the self‑funded employer health plan market and position the company’s services within that context.

Marpai indicates that its services are value‑oriented, with an emphasis on aligning health plan performance with employer budgets. The Marpai Saves initiative is described as an effort to deliver the healthiest member population within the constraints of each health plan’s budget, reflecting the company’s stated focus on health outcomes and cost management for self‑funded plans.

Capital markets and corporate actions

Marpai’s SEC filings show that the company has engaged in several private placement transactions. In multiple Form 8‑K filings, Marpai reports entering into Securities Purchase Agreements with investors, including HillCour Investment Fund, LLC and other purchasers, for the sale of shares of Class A common stock and, in some cases, warrants to purchase additional shares. These transactions are described as unregistered sales of equity securities relying on exemptions under the Securities Act of 1933.

The company’s filings state that the proceeds from these offerings are intended for working capital and general corporate purposes. Marpai also reports that its Class A common stock is registered under Section 12 of the Securities Exchange Act and is listed on the OTCQX Market under the symbol MRAI. In a separate 8‑K filing, Marpai discloses an amendment to its certificate of incorporation to authorize preferred stock, described as blank‑check preferred stock, subject to terms determined by the board of directors.

Governance and stockholder information

In its definitive proxy statement (DEF 14A), Marpai provides information about its annual meeting of stockholders, board composition and governance matters. The proxy statement outlines proposals such as the election of directors, the ratification of the company’s independent registered public accounting firm and the authorization of preferred stock. It also describes the voting rights of holders of Class A common stock and the procedures for stockholders to participate in the annual meeting.

The proxy materials confirm that Marpai, Inc. is incorporated in Delaware and that its principal U.S. office is located in Tampa, Florida. The company identifies itself in these materials as Marpai, Inc. and uses the same description of its business as in its press releases, emphasizing its role as a technology platform company with TPA, PBM and value‑oriented health plan services.

Position within the finance and insurance sector

Within the broader finance and insurance sector, Marpai aligns itself with the insurance agencies and brokerages industry classification, while its own descriptions focus on TPA and PBM services for employer health plans. The company’s activities, as described in its public communications, sit at the intersection of healthcare administration, pharmacy benefits and financial management of employer‑sponsored health benefits.

Marpai’s disclosures highlight its focus on cost control, operational efficiency and technology‑enabled administration of health benefits. The company’s public financial reports discuss efforts to reduce operating expenses and to improve margins, which it associates with a broader transformation strategy within its business model.

Key themes from recent disclosures

Across its recent news releases and SEC filings, several themes recur in Marpai’s description of its business:

  • A focus on self‑funded employer health plans and the TPA sector.
  • The integration of TPA, PBM and value‑oriented health plan services within a technology platform.
  • Nationwide operations with access to provider networks including Aetna and Cigna.
  • Initiatives such as Marpai Saves and MarpaiRx, which the company associates with cost management and member health outcomes.
  • Use of private placements and other capital markets transactions to support working capital and corporate purposes.

Investors researching Marpai, Inc. (MRAI) can use these disclosures to understand how the company presents its role in the self‑funded healthcare administration space, the services it reports providing and the markets it targets.

Stock Performance

$0.5900
0.00%
0.00
Last updated: January 16, 2026 at 14:37
-44.05 %
Performance 1 year

Insider Radar

Net Buyers
90-Day Summary
800,000
Shares Bought
0
Shares Sold
7
Transactions
Most Recent Transaction
SHIV SAGIV (Director) bought 100,000 shares on Nov 7, 2025
Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

$7,385,000
Revenue (TTM)
-$4,346,000
Net Income (TTM)
-$3,585,000
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Marpai (MRAI)?

The current stock price of Marpai (MRAI) is $0.59 as of January 16, 2026.

What is the market cap of Marpai (MRAI)?

The market cap of Marpai (MRAI) is approximately 6.7M. Learn more about what market capitalization means .

What is the revenue (TTM) of Marpai (MRAI) stock?

The trailing twelve months (TTM) revenue of Marpai (MRAI) is $7,385,000.

What is the net income of Marpai (MRAI)?

The trailing twelve months (TTM) net income of Marpai (MRAI) is -$4,346,000.

What is the earnings per share (EPS) of Marpai (MRAI)?

The diluted earnings per share (EPS) of Marpai (MRAI) is -$0.46 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Marpai (MRAI)?

The operating cash flow of Marpai (MRAI) is -$3,585,000. Learn about cash flow.

What is the profit margin of Marpai (MRAI)?

The net profit margin of Marpai (MRAI) is -58.85%. Learn about profit margins.

What is the operating margin of Marpai (MRAI)?

The operating profit margin of Marpai (MRAI) is -55.04%. Learn about operating margins.

What is the current ratio of Marpai (MRAI)?

The current ratio of Marpai (MRAI) is 0.82, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Marpai (MRAI)?

The operating income of Marpai (MRAI) is -$4,065,000. Learn about operating income.

What does Marpai, Inc. (MRAI) do?

According to its public disclosures, Marpai, Inc. is a technology platform company that operates subsidiaries providing Third-Party Administration (TPA), Pharmacy Benefit Management (PBM) and value-oriented health plan services to employers that directly pay for employee health benefits.

Which market does Marpai, Inc. primarily serve?

Marpai states that it primarily competes in the TPA sector serving self-funded employer health plans. These plans involve employers that directly pay for employee health benefits rather than purchasing fully insured products.

On which exchange does Marpai, Inc. trade and what is its ticker?

Marpai, Inc.’s Class A common stock is listed on the OTCQX Market under the trading symbol MRAI, as disclosed in its SEC filings.

What services does Marpai provide through its subsidiaries?

The company reports that its subsidiaries provide TPA services, PBM services and value-oriented health plan services. These activities are directed at employers that directly fund their employees’ health benefits.

What is MarpaiRx?

In company news, Marpai describes MarpaiRx as its pharmacy benefit management (PBM) solution. The company characterizes MarpaiRx as part of its Marpai Saves vision and states that it is designed to offer transparency and cost reductions for health plans and members.

What is the Marpai Saves initiative?

Marpai’s public statements describe Marpai Saves as an initiative through which the company works to deliver the healthiest member population for the health plan budget, aligning member health outcomes with the financial goals of self-funded employer health plans.

Which provider networks does Marpai mention in its disclosures?

Marpai states that it offers access to leading provider networks including Aetna and Cigna. It also reports renewing its agreement to access the Aetna Signature Administrator PPO network and notes that it operates nationwide.

How does Marpai describe its use of technology?

Marpai refers to itself as a technology platform company and reports initiatives in automation and data-driven claims management. It links these efforts to its TPA and PBM services and to its goal of managing healthcare costs for self-funded employer health plans.

What capital raising activities has Marpai reported?

In several Form 8-K filings, Marpai reports entering into Securities Purchase Agreements for private placements of Class A common stock and, in some cases, warrants. The company states that these offerings are exempt from registration under the Securities Act and that proceeds are intended for working capital and general corporate purposes.

Where is Marpai, Inc. based?

Marpai’s SEC filings and proxy statement identify the company as Marpai, Inc., with its principal U.S. office located in Tampa, Florida.